DR. KIMBERLY BROUWER


Education:

  • 2000 – PhD Molecular Epidemiology,  Johns Hopkins University.
  • 1994 – Integrative Biology, University of California, Berkeley.

Academic appointments:

  • Vice Chair for Public Health Education and Interim Global Health Division Chief for the Department of Family Medicine & Public Health.
  • Co-directs the Global Health track of the SDSU/UCSD Joint Doctoral Program in Public Health
  • Affiliated Researcher at CISIDAT.

Research interests:

  • HIV/AIDS, Vector-borne diseases, Tropical parasitic diseases, Substance Use, Refugee Health, Migrant Health, Access to and Retention in Healthcare, Mixed Methods research, Spatial and Social epidemiology, Infectious Disease epidemiology

Featured projects: 

  • She is currently collaborating with Mexican and Guatemalan officials in studies on substance use, HIV and sexually transmitted infections, in an effort to inform appropriate public health interventions.

SELECTED PUBLICATIONS

  • Prevalence and correlates of cervical abnormalities among female sex workers in Tijuana, Mexico. Bristow CC, Brown B, Marg L, Iñiguez RI, Meckel-Parker K, Silverman JG, Magis-Rodriguez C, Gaines TL, Brouwer KC. Int J STD AIDS. 2019 Aug;30(9):861-867.
  • Historical trends in the production and consumption of illicit drugs in Mexico: implications for the prevention of blood borne infections. Bucardo J, Brouwer KC, Magis-Rodríguez C, Ramos R, Fraga M, Perez SG, Patterson TL, Strathdee SA. Drug Alcohol Depend. 2005 Sep 1;79(3):281-93.
  • “Vivo para consumirla y la consumo para vivir” [“I live to inject and inject to live”]: high-risk injection behaviors in Tijuana, Mexico. Strathdee SA, Fraga WD, Case P, Firestone M, Brouwer KC, Perez SG, Magis C, Fraga MA. J Urban Health. 2005 Sep;82(3 Suppl 4):iv58-73.
  • HIV prevalence and correlates of receptive needle sharing among injection drug users in the Mexican-U.s. border city of Tijuana. Magis-Rodríguez C, Brouwer KC, Morales S, Gayet C, Lozada R, Ortiz-Mondragón R, Ricketts EP, Strathdee SA. J Psychoactive Drugs. 2005 Sep;37(3):333-9.
  • Estimated numbers of men and women infected with HIV/AIDS in Tijuana, Mexico. Brouwer KC, Strathdee SA, Magis-Rodríguez C, Bravo-García E, Gayet C, Patterson TL, Bertozzi SM, Hogg RS. J Urban Health. 2006 Mar;83(2):299-307.
  • Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.S. White EF, Garfein RS, Brouwer KC, Lozada R, Ramos R, Firestone-Cruz M, Pérez SG, Magis-Rodríguez C, Conde-Glez CJ, Strathdee SA. Salud Publica Mex. 2007 May-Jun;49(3):165-72.
  • High-risk sexual and drug using behaviors among male injection drug users who have sex with men in 2 Mexico-US border cities. Deiss RG, Brouwer KC, Loza O, Lozada RM, Ramos R, Cruz MA, Patterson TL, Heckathorn DD, Frost SD, Strathdee SA. Sex Transm Dis. 2008 Mar;35(3):243-9.
  • Individual, social, and environmental influences associated with HIV infection among injection drug users in Tijuana, Mexico. Strathdee SA, Lozada R, Pollini RA, Brouwer KC, Mantsios A, Abramovitz DA, Rhodes T, Latkin CA, Loza O, Alvelais J, Magis-Rodriguez C, Patterson TL. J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):369-76.
  • Shooting gallery attendance among IDUs in Tijuana and Ciudad Juarez, Mexico: correlates, prevention opportunities, and the role of the environment. Philbin M, Pollini RA, Ramos R, Lozada R, Brouwer KC, Ramos ME, Firestone-Cruz M, Case P, Strathdee SA. AIDS Behav. 2008 Jul;12(4):552-60.
  • The color of meth: is it related to adverse health outcomes? An exploratory study in Tijuana, Mexico. Strathdee SA, Case P, Lozada R, Mantsios AR, Alvelais J, Pu M, Brouwer KC, Miller CL, Patterson TL. Am J Addict. 2008 Mar-Apr;17(2):111-5.